Study to Evaluate the Pharmacokinetics (movement of drugs within the body), Safety and Tolerability of Brazikumab in Healthy Chinese and White Participants

Trial Identifier:	D5271C00004
Sponsor:	AstraZeneca
Start Date:	October 2021
Primary Completion Date:	October 2022
Study Completion Date:	October 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Chinese (Simplified) Translation
	Chinese (Traditional) Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.